Dudediligence.

Abeona Therapeutics Inc

ABEONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$400,000Jun ’25$5.4MDec ’25$8.7MMar ’26$11.4MJun ’26
Net income, by quarter
−$30.3MSep ’24−$9.3MDec ’24−$12.0MMar ’25$108.8MJun ’25−$5.2MSep ’25−$162.8MDec ’25−$17.1MMar ’26−$20.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.0M$1.4M$3.5Mnone on file$5.8M
Gross profitnone on filenone on filenone on filenone on file$4.3M
Operating income−$89.8M−$50.9M−$47.1M−$64.2M−$89.4M
Net income−$84.9M−$39.7M−$54.2M−$63.7M−$71.2M
Operating cash flow−$65.7M−$43.5M−$37.0M−$56.0M−$76.3M
Free cash flow−$69.8M−$43.6M−$37.3M−$58.5M−$84.3M
Cash$32.9M$14.2M$14.5M$23.4M$78.4M
Debtnone on filenone on filenone on file$19.0M$20.0M
Shares outstanding5.9M17.7M26.5M45.6M55.0M